Company / Financials
IRONWOOD PHARMACEUTICALS INC Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$296.2M
FY2025 · -27.9% YoY
Net Income
$24.0M
FY2025 · -86.3% YoY
Profit Margin
8.1%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$396.9M
FY2025
Total Debt
-
FY2025
Equity
-$261.8M
FY2025
ROA
6.0%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$296.2M-27.9% YoYNet Income HistoryProfit after all expenses and taxes$24.0M-86.3% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$3.1MOperating Income HistoryProfit from core business operations before interest and taxes$98.5M-60.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$82.3M-29.1% YoYR&D Expense HistoryResearch and development spending$95.1M+114.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$21.6MIncome Tax HistoryTotal income tax expense$46.0M-40.5% YoYEPS (Basic) HistoryBasic earnings per share$0.01-99.1% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.01-99.0% YoY